サマリー

Market Analysis and Insights:世界と中国の第一次抗体市場
本レポートは、世界と中国の第一次抗体市場に焦点を当てています。
2020年の世界の第一次抗体市場規模はXX百万米ドルで、2021-2027年の間にXX％のCAGRで、2027年末にはXX百万米ドルに達すると予想されています。中国では、第一次抗体の市場規模は、2020年のXX百万米ドルから2027年にはXX百万米ドルまで、予測期間中にXX％のCAGRで成長すると予測されています。

世界の第一次抗体の範囲と市場規模
第一次抗体市場は、地域（国）別、プレイヤー別、タイプ別、アプリケーション別に分類されています。世界の第一次抗体市場に参加するプレイヤー、ステークホルダー、その他の参加者は、本レポートを強力なリソースとして活用することで、優位に立つことができるでしょう。セグメント分析では、地域（国）別、タイプ別、アプリケーション別に、2016年から2027年までの収益と予測に焦点を当てています。
中国市場については、2016年から2027年の期間で、プレーヤー別、タイプ別、アプリケーション別の一次抗体市場規模に焦点を当てています。主要プレイヤーには、中国で重要な役割を果たしているグローバルプレイヤーとローカルプレイヤーが含まれています。

タイプ別セグメント
モノクローナル抗体
ポリクローナル(Polyclonal)抗体

用途別セグメント
病院
ライフサイエンス
研究所

地域別
北アメリカ
アメリカ
カナダ
ヨーロッパ
ドイツ
フランス
U.K.
イタリア
ロシア
アジアパシフィック
中国
日本
韓国
インド
オーストラリア
中国 台湾
インドネシア
タイ
マレーシア
ラテンアメリカ
メキシコ
ブラジル
アルゼンチン
中近東・アフリカ
トルコ
サウジアラビア
UAE

会社別
バイオラッド
Biorbyt
アブカム
サーモフィッシャーサイエンティフィック
クリエイティブ・ダイアグノスティックス
ノーバス・バイオロジカルズ
SouthernBiotech
ボスター・バイオ
オリジーン
ジェンスクリプト・バイオテック(Genscript Biotech)
プロテインテック
ロシュ・ダイアグノスティックス
ハイテスト

ページTOPに戻る

目次

1 Study Coverage
1.1 Primary Antibody Product Introduction
1.2 Market by Type
1.2.1 Global Primary Antibody Market Size Growth Rate by Type
1.2.2 Monoclonal Antibodies
1.2.3 Polyclonal Antibody
1.3 Market by Application
1.3.1 Global Primary Antibody Market Size Growth Rate by Application
1.3.2 Hospital
1.3.3 Life Sciences
1.3.4 Laboratory
1.4 Study Objectives
1.5 Years Considered

2 Executive Summary
2.1 Global Primary Antibody Market Size, Estimates and Forecasts
2.1.1 Global Primary Antibody Revenue 2016-2027
2.1.2 Global Primary Antibody Sales 2016-2027
2.2 Global Primary Antibody, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Primary Antibody Historical Market Size by Region (2016-2021)
2.3.1 Global Primary Antibody Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Primary Antibody Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Primary Antibody Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Primary Antibody Sales Forecast by Region (2022-2027)
2.4.2 Global Primary Antibody Revenue Forecast by Region (2022-2027)

3 Global Primary Antibody Competitor Landscape by Players
3.1 Global Top Primary Antibody Manufacturers by Sales
3.1.1 Global Primary Antibody Sales by Manufacturer (2016-2021)
3.1.2 Global Primary Antibody Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Primary Antibody Manufacturers by Revenue
3.2.1 Key Primary Antibody Manufacturers Covered: Ranking by Revenue
3.2.2 Global Primary Antibody Revenue by Manufacturers (2016-2021)
3.2.3 Global Primary Antibody Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Primary Antibody Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Primary Antibody Revenue in 2020
3.2.6 Global Primary Antibody Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Primary Antibody Price by Manufacturers
3.4 Global Primary Antibody Manufacturing Base Distribution, Product Types
3.4.1 Primary Antibody Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Primary Antibody Product Type
3.4.3 Date of International Manufacturers Enter into Primary Antibody Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2016-2027)
4.1 Global Primary Antibody Market Size by Type (2016-2021)
4.1.1 Global Primary Antibody Sales by Type (2016-2021)
4.1.2 Global Primary Antibody Revenue by Type (2016-2021)
4.1.3 Primary Antibody Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Primary Antibody Market Size Forecast by Type (2022-2027)
4.2.1 Global Primary Antibody Sales Forecast by Type (2022-2027)
4.2.2 Global Primary Antibody Revenue Forecast by Type (2022-2027)
4.2.3 Primary Antibody Average Selling Price (ASP) Forecast by Type (2022-2027)

5 Breakdown Data by Application (2016-2027)
5.1 Global Primary Antibody Market Size by Application (2016-2021)
5.1.1 Global Primary Antibody Sales by Application (2016-2021)
5.1.2 Global Primary Antibody Revenue by Application (2016-2021)
5.1.3 Primary Antibody Price by Application (2016-2021)
5.2 Primary Antibody Market Size Forecast by Application (2022-2027)
5.2.1 Global Primary Antibody Sales Forecast by Application (2022-2027)
5.2.2 Global Primary Antibody Revenue Forecast by Application (2022-2027)
5.2.3 Global Primary Antibody Price Forecast by Application (2022-2027)

6 China by Players, Type and Application
6.1 China Primary Antibody Market Size YoY Growth 2016-2027
6.1.1 China Primary Antibody Sales YoY Growth 2016-2027
6.1.2 China Primary Antibody Revenue YoY Growth 2016-2027
6.1.3 China Primary Antibody Market Share in Global Market 2016-2027
6.2 China Primary Antibody Market Size by Players (International and Local Players)
6.2.1 China Top Primary Antibody Players by Sales (2016-2021)
6.2.2 China Top Primary Antibody Players by Revenue (2016-2021)
6.3 China Primary Antibody Historic Market Review by Type (2016-2021)
6.3.1 China Primary Antibody Sales Market Share by Type (2016-2021)
6.3.2 China Primary Antibody Revenue Market Share by Type (2016-2021)
6.3.3 China Primary Antibody Price by Type (2016-2021)
6.4 China Primary Antibody Market Estimates and Forecasts by Type (2022-2027)
6.4.1 China Primary Antibody Sales Forecast by Type (2022-2027)
6.4.2 China Primary Antibody Revenue Forecast by Type (2022-2027)
6.4.3 China Primary Antibody Price Forecast by Type (2022-2027)
6.5 China Primary Antibody Historic Market Review by Application (2016-2021)
6.5.1 China Primary Antibody Sales Market Share by Application (2016-2021)
6.5.2 China Primary Antibody Revenue Market Share by Application (2016-2021)
6.5.3 China Primary Antibody Price by Application (2016-2021)
6.6 China Primary Antibody Market Estimates and Forecasts by Application (2022-2027)
6.6.1 China Primary Antibody Sales Forecast by Application (2022-2027)
6.6.2 China Primary Antibody Revenue Forecast by Application (2022-2027)
6.6.3 China Primary Antibody Price Forecast by Application (2022-2027)

7 North America
7.1 North America Primary Antibody Market Size YoY Growth 2016-2027
7.2 North America Primary Antibody Market Facts & Figures by Country
7.2.1 North America Primary Antibody Sales by Country (2016-2021)
7.2.2 North America Primary Antibody Revenue by Country (2016-2021)
7.2.3 United States
7.2.4 Canada

8 Asia Pacific
8.1 Asia Pacific Primary Antibody Market Size YoY Growth 2016-2027
8.2 Asia Pacific Primary Antibody Market Facts & Figures by Region
8.2.1 Asia Pacific Primary Antibody Sales by Region (2016-2021)
8.2.2 Asia Pacific Primary Antibody Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia

9 Europe
9.1 Europe Primary Antibody Market Size YoY Growth 2016-2027
9.2 Europe Primary Antibody Market Facts & Figures by Country
9.2.1 Europe Primary Antibody Sales by Country (2016-2021)
9.2.2 Europe Primary Antibody Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy

10 Latin America
10.1 Latin America Primary Antibody Market Size YoY Growth 2016-2027
10.2 Latin America Primary Antibody Market Facts & Figures by Country
10.2.1 Latin America Primary Antibody Sales by Country (2016-2021)
10.2.2 Latin America Primary Antibody Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina

11 Middle East and Africa
11.1 Middle East and Africa Primary Antibody Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Primary Antibody Market Facts & Figures by Country
11.2.1 Middle East and Africa Primary Antibody Sales by Country (2016-2021)
11.2.2 Middle East and Africa Primary Antibody Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 UAE

12 Company Profiles
12.1 Bio-Rad
12.1.1 Bio-Rad Corporation Information
12.1.2 Bio-Rad Description and Business Overview
12.1.3 Bio-Rad Primary Antibody Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Bio-Rad Primary Antibody Products Offered
12.1.5 Bio-Rad Recent Development
12.2 Biorbyt
12.2.1 Biorbyt Corporation Information
12.2.2 Biorbyt Description and Business Overview
12.2.3 Biorbyt Primary Antibody Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Biorbyt Primary Antibody Products Offered
12.2.5 Biorbyt Recent Development
12.3 Abcam
12.3.1 Abcam Corporation Information
12.3.2 Abcam Description and Business Overview
12.3.3 Abcam Primary Antibody Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Abcam Primary Antibody Products Offered
12.3.5 Abcam Recent Development
12.4 Thermo Fisher Scientific
12.4.1 Thermo Fisher Scientific Corporation Information
12.4.2 Thermo Fisher Scientific Description and Business Overview
12.4.3 Thermo Fisher Scientific Primary Antibody Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Thermo Fisher Scientific Primary Antibody Products Offered
12.4.5 Thermo Fisher Scientific Recent Development
12.5 Creative Diagnostics
12.5.1 Creative Diagnostics Corporation Information
12.5.2 Creative Diagnostics Description and Business Overview
12.5.3 Creative Diagnostics Primary Antibody Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Creative Diagnostics Primary Antibody Products Offered
12.5.5 Creative Diagnostics Recent Development
12.6 Novus Biologicals
12.6.1 Novus Biologicals Corporation Information
12.6.2 Novus Biologicals Description and Business Overview
12.6.3 Novus Biologicals Primary Antibody Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Novus Biologicals Primary Antibody Products Offered
12.6.5 Novus Biologicals Recent Development
12.7 SouthernBiotech
12.7.1 SouthernBiotech Corporation Information
12.7.2 SouthernBiotech Description and Business Overview
12.7.3 SouthernBiotech Primary Antibody Sales, Revenue and Gross Margin (2016-2021)
12.7.4 SouthernBiotech Primary Antibody Products Offered
12.7.5 SouthernBiotech Recent Development
12.8 Boster Bio
12.8.1 Boster Bio Corporation Information
12.8.2 Boster Bio Description and Business Overview
12.8.3 Boster Bio Primary Antibody Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Boster Bio Primary Antibody Products Offered
12.8.5 Boster Bio Recent Development
12.9 OriGene
12.9.1 OriGene Corporation Information
12.9.2 OriGene Description and Business Overview
12.9.3 OriGene Primary Antibody Sales, Revenue and Gross Margin (2016-2021)
12.9.4 OriGene Primary Antibody Products Offered
12.9.5 OriGene Recent Development
12.10 Genscript Biotech
12.10.1 Genscript Biotech Corporation Information
12.10.2 Genscript Biotech Description and Business Overview
12.10.3 Genscript Biotech Primary Antibody Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Genscript Biotech Primary Antibody Products Offered
12.10.5 Genscript Biotech Recent Development
12.11 Bio-Rad
12.11.1 Bio-Rad Corporation Information
12.11.2 Bio-Rad Description and Business Overview
12.11.3 Bio-Rad Primary Antibody Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Bio-Rad Primary Antibody Products Offered
12.11.5 Bio-Rad Recent Development
12.12 Roche Diagnostics
12.12.1 Roche Diagnostics Corporation Information
12.12.2 Roche Diagnostics Description and Business Overview
12.12.3 Roche Diagnostics Primary Antibody Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Roche Diagnostics Products Offered
12.12.5 Roche Diagnostics Recent Development
12.13 HyTest
12.13.1 HyTest Corporation Information
12.13.2 HyTest Description and Business Overview
12.13.3 HyTest Primary Antibody Sales, Revenue and Gross Margin (2016-2021)
12.13.4 HyTest Products Offered
12.13.5 HyTest Recent Development

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Primary Antibody Industry Trends
13.2 Primary Antibody Market Drivers
13.3 Primary Antibody Market Challenges
13.4 Primary Antibody Market Restraints

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Primary Antibody Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer